Question 1

What is LOPJLB’s current signal on JSPR?

Accepted Answer

LOPJLB’s latest quantitative signal on Jasper Therapeutics, Inc. (JSPR) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is JSPR in?

Accepted Answer

Jasper Therapeutics, Inc. (JSPR) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Jasper Therapeutics, Inc. (JSPR) do?

Accepted Answer

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The companyâs lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commerci…

Question 4

Where is Jasper Therapeutics, Inc. based / listed?

Accepted Answer

Jasper Therapeutics, Inc. is based in US, listed on NASDAQ.

Jasper Therapeutics, Inc. (JSPR)

Key stats

Prediction markets

Company news